Plain-English translation of NCT05938192 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is studying patients who have been treated for HPV-related lesions (abnormal tissue changes caused by the human papillomavirus) in the cervix or vagina. Researchers want to understand whether receiving an HPV vaccine after surgery helps prevent these lesions from coming back, and which patients are most likely to experience recurrence.
HPV-related lesions can return after surgery, and doctors want to identify which patients are at highest risk and whether adding vaccination to surgical treatment can improve outcomes and reduce the chance of the disease returning.
You likely qualify if…
You likely don't qualify if…
As a participant, you will be followed over time after receiving surgical treatment for your HPV-related lesions, with or without an HPV vaccine. Researchers will monitor you through follow-up visits and assessments to track whether your lesions return and to gather information about factors that may predict recurrence.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
Italy
Enrollment target
~200 participants
Started
July 2020
Primary completion
December 2026
Age range
18 Years and older
Sex
Female only
Last updated on clinicaltrials.gov in May 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Giorgio Bogani, md
Giorgio Bogani
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.